Valter Torri

Mario Negri Institute for Pharmacological Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “TERAVOLT: Thoracic Cancers International COVID-19 Collaboration”.

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration

Cancer Cell(2020)10.1016/j.ccell.2020.05.008

N/A

0.614DataRank · unranked

59 citations

Annalisa Trama, Valter Torri, Alessandro De Toma, Giuseppe Viscardi, Alessio Cortellini +12 more

Overall survival (OS) and long-term disease-free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin and fluoropyrimidine-based therapy for patients (pts) with stage III colon cancer (CC): Final results from the IDEA (International Duration Evaluation of Adj chemotherapy) collaboration.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4004

N/A

0DataRank · unranked

36 citations

Thierry André, Jeffrey A. Meyerhardt, Axel Grothey, Timothy Iveson, Takayuki Yoshino +15 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6

N/A

0DataRank · unranked

83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231198446

N/A

0DataRank · unranked

7 citations

Jacobi Hines, Valter Torri, Luca Porcu, Jessica Donington, Christine M. Bestvina +5 more